Milestone Scientific - MLSS Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $4.00
  • Forecasted Upside: 433.33 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.75
▼ -0.04 (-5.06%)

This chart shows the closing price for MLSS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Milestone Scientific Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MLSS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MLSS

Analyst Price Target is $4.00
▲ +433.33% Upside Potential
This price target is based on 0 analysts offering 12 month price targets for Milestone Scientific in the last 3 months. The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 433.33% upside from the last price of $0.75.

This chart shows the closing price for MLSS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Milestone Scientific. This rating has held steady since September 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/11/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/8/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/6/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/6/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/5/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/3/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/3/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/4/2022Maxim GroupLower Target$6.00 ➝ $4.00
9/16/2020Northland SecuritiesInitiated CoverageMarket Perform
8/17/2020Maxim GroupReiterated RatingBuy$4.00
6/23/2020Maxim GroupReiterated RatingBuy$4.00
5/19/2020Maxim GroupReiterated RatingBuy$3.00
4/1/2020Maxim GroupReiterated RatingBuy$3.00
11/15/2019Maxim GroupReiterated RatingBuy$2.00
10/18/2019Maxim GroupReiterated RatingBuy$2.00
8/16/2019Maxim GroupReiterated RatingBuy$1.00
11/16/2018Maxim GroupLower TargetBuy ➝ Buy$3.00 ➝ $1.50
4/4/2018Maxim GroupReiterated RatingBuy$4.00
11/15/2017Maxim GroupReiterated RatingBuy$4.00
10/6/2017Maxim GroupReiterated RatingBuy$4.00
(Data available from 10/4/2017 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/7/2022
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/6/2022
  • 4 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/6/2022
  • 4 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/5/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/5/2022
  • 3 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/4/2022
  • 4 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/3/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/3/2022

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Milestone Scientific logo
Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey.
Read More

Today's Range

Now: $0.75
Low: $0.70
High: $0.87

50 Day Range

MA: N/A

52 Week Range

Now: $0.75
Low: $0.63
High: $3.00

Volume

78,871 shs

Average Volume

115,763 shs

Market Capitalization

$51.69 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.34

Frequently Asked Questions

What sell-side analysts currently cover shares of Milestone Scientific?

The following Wall Street research analysts have issued reports on Milestone Scientific in the last year: Maxim Group.
View the latest analyst ratings for MLSS.

What is the current price target for Milestone Scientific?

1 Wall Street analysts have set twelve-month price targets for Milestone Scientific in the last year. Their average twelve-month price target is $4.00, suggesting a possible upside of 433.3%. Maxim Group has the highest price target set, predicting MLSS will reach $4.00 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $4.00 for Milestone Scientific in the next year.
View the latest price targets for MLSS.

What is the current consensus analyst rating for Milestone Scientific?

Milestone Scientific currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MLSS.

What other companies compete with Milestone Scientific?

How do I contact Milestone Scientific's investor relations team?

Milestone Scientific's physical mailing address is 220 S Orange Ave, LIVINGSTON, NJ 07039-5804, United States. The medical instruments supplier's listed phone number is (973) 535-2717 and its investor relations email address is [email protected] The official website for Milestone Scientific is www.milesci.com. Learn More about contacing Milestone Scientific investor relations.